Incyte Corp.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 8.06%164.180.0%$3009.11m
BNGOBioNano Genomics, Inc. -5.39%11.550.0%$2382.24m
GILDGilead Sciences, Inc. -1.06%65.991.0%$648.37m
AMGNAmgen, Inc. -1.52%254.661.3%$575.74m
REGNRegeneron Pharmaceuticals, Inc. -4.69%518.572.7%$474.62m
ALXNAlexion Pharmaceuticals, Inc. -2.11%158.332.0%$465.29m
ILMNIllumina, Inc. 0.70%423.503.5%$446.92m
CRSPCRISPR Therapeutics AG -3.24%164.030.6%$431.11m
NVAXNovavax, Inc. 2.38%130.1992.9%$416.81m
VRTXVertex Pharmaceuticals, Inc. -4.55%226.831.9%$362.28m
SRPTSarepta Therapeutics, Inc. -1.84%90.9513.8%$337.11m
BNTXBioNTech SE 3.10%109.580.0%$317.47m
BIIBBiogen, Inc. -2.16%265.801.7%$316.62m
EXASEXACT Sciences Corp. -2.26%137.8519.6%$245.97m
SRNESorrento Therapeutics, Inc. 36.26%14.201.4%$244.37m

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.